Novo Nordisk (NVO) Stock Plummets 8%: Overblown Sell-Off or Real Trouble Ahead?
Key Takeaways Novo Nordisk shares plunged almost 8% on Monday, marking the largest single-day decline since February CEO Mike Doustdar announced the company is exploring acquisitions to addre




